ACSL3 and cholangiocarcinoma: These findings provide precise insights into the mechanisms underlying ferroptosis resistance in CCA, highlighting the ACSL3-mediated pathway as a promising target for precision therapeutic strategies aimed at improving survival in high-risk CCA patients with elevated ACSL3 expression.